Mandate

Vinge advises in conjunction with sale of shares in Oatly

December 08, 2016

Vinge has advised on the sale of the shares in Oatly.

Oatly was formed in the 1990s as a spin-off from a research facility at Lund University. Today, Oatly has established itself as one of the Nordic region’s leading trademarks within ethical and sustainable lifestyle. Oatly is currently active on 20 markets in Europe and Asia, and its turnover last year was approximately SEK 369 million.

Vinge’s team consisted of responsible partner Johan Larsson together with, among others, associates Joacim Rydergård and Johanna Wiberg (M&A), Malin Malm Waerme (intellectual property), senior counsel Qun Gu (China practice) and Pernilla Warg (project assistant).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025